Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study
Introduction For people with type 2 diabetes mellitus (T2DM) who require an antidiabetic drug as an add-on to metformin, there is controversy about whether newer drug classes such as dipeptidyl peptidase-4 inhibitors (DPP4i) or sodium-glucose co-transporter-2 inhibitors (SGLT2i) reduce the risk of l...
Main Authors: | Bidulka, P, O'Neill, S, Basu, A, Wilkinson, S, Silverwood, RJ, Charlton, P, Briggs, A, Adler, AI, Khunti, K, Tomlinson, LA, Smeeth, L, Douglas, IJ, Grieve, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2021
|
Similar Items
-
Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study
by: Kamlesh Khunti, et al.
Published: (2021-09-01) -
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data
by: Bidulka, P, et al.
Published: (2024) -
Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care
by: Wilkinson S, et al.
Published: (2018-11-01) -
The PERMIT guidelines for designing and implementing all stages of personalised medicine research
by: Paula Garcia, et al.
Published: (2024-11-01) -
Towards derivation of a distinct signature permitting personalised treatment in prostate cancer
by: Lamb, A, et al.
Published: (2013)